Manchester clears first hurdle in €170 million biobank building boom

June 19, 2008

The University of Manchester has been successful in gaining major European Union funding to begin joint planning of how millions of biological samples, such as DNA, can be managed and made available to research scientists across Europe.

The Centre for Integrated Genomic Medical Research (CIGMR), based in the School of Translational Medicine, is playing a key role in developing the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) alongside scientists and funding agencies in other European member states.

This infrastructure will link new and existing biobanks across the continent and planners anticipate the cost of construction will exceed €170 million.

The initial planning phase will last two years and cost €5 million, the sum announced today (Thursday). It will answer key questions, including whether the infrastructure will comprise a number of physical buildings in locations across Europe or whether a virtual infrastructure would be the best option, or a combination of both.

Dr Martin Yuille, Reader in Biological Resource Management and associate coordinator for the planning phase, said: "This European biobanking infrastructure is as important to biomedical science as CERN is to Physics or Jodrell is to Astronomy.

"It will counter fragmentation in Europe that is impeding access to valuable resources essential for translating the human genome sequence into health benefits."

Advances in robotics, miniaturisation and imaging are allowing detailed molecular analysis of biological samples. For biomedicine this means that samples from very large numbers of patients and healthy individuals need to be studied to discover, for example, the genes that underlie our risk of diseases like heart disease, cancer or Alzheimer's.

Manchester is already a leading centre for this area of research. It is host to the UK Biobank - a world-leading study of how genes and lifestyle contribute to health and disease.

It also leads the UK DNA Banking Network (UDBN), the biobanking facility that manages UK samples and associated data from key priority diseases, such as cancer, mental health, heart disease, ageing and diabetes.

UDBN has distributed more than 40,000 samples to labs worldwide. The facility was built with support from the Medical Research Council which continues to maintain it. The Council has recently announced that it plans to enter into discussions with other funders to explore their potential interest in developing joint biobanking facilities for large DNA sample collections.

Professor Bill Ollier, Director of CIGMR in Manchester, said: "We are pleased that The University of Manchester is continuing to play a key role in facilitating cutting-edge science in medical research and that MRC is committed to work along with other funders to develop the UK's biobanking infrastructure."
-end-
Notes for editors:

For further information about CIGMR visit: www.medicine.manchester.ac.uk/cigmr

For further information about UK Biobank visit: www.ukbiobank.ac.uk

For further information about UK DNA Banking Network visit: www.dna-network.ac.uk

University of Manchester

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.